Annexon Quarterly Cash Flow Statement
NASDAQ: ANNXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.02+0.02 (+0.50%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Annexon free cash flow
In the quarter ended Jun 30, 2026, Annexon generated -$48.0 million of operating cash flow and spent $137,000 on capital expenditures. That left free cash flow of -$48.1 million.
Summary generated from market data by MetaCap's automated system. Methodology
Annexon cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q4 20252025-12-31 | Q3 20252025-09-30 | Q2 20252025-06-30 | Q1 20252025-03-31 | Q4 20242024-12-31 | Q3 20242024-09-30 | Q2 20242024-06-30 | Q1 20242024-03-31 | Q4 20232023-12-31 | Q3 20232023-09-30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | -55.35M | -44.14M | -48.26M | -54.92M | -49.16M | -54.36M | -48.59M | -34.82M | -29.61M | -25.18M | -27.89M | -32.48M |
| Net Income growth (YoY) | — | — | — | — | — | — | — | — | — | — | — | — |
| Depreciation & Amortization | 540.00K | 539.00K | 543.00K | 546.00K | 540.00K | 537.00K | 537.00K | 538.00K | 537.00K | 538.00K | 538.00K | 538.00K |
| Stock-Based Compensation | 4.81M | 4.16M | 3.31M | 3.83M | 4.21M | 5.08M | 5.22M | 4.61M | 4.94M | 4.66M | 4.37M | 4.55M |
| Change in Working Capital | 2.60M | -6.64M | -760.00K | 2.30M | 7.90M | 2.87M | 10.13M | 4.21M | 4.12M | -6.53M | -374.00K | -99.00K |
| Operating Cash Flow | -48.01M | -46.80M | -45.93M | -52.30M | -38.07M | -50.05M | -36.02M | -32.02M | -21.71M | -28.27M | -23.48M | -28.29M |
| Capital Expenditures | -137.00K | 0 | 0 | -48.00K | -15.00K | -74.00K | -6.00K | — | — | — | -7.00K | -19.00K |
| Investing Cash Flow | 39.97M | 27.06M | -26.52M | 45.87M | 73.08M | 97.62M | 1.01M | -45.93M | -96.58M | -77.30M | -2.18M | 47.84M |
| Financing Cash Flow | 32.10M | 32.90M | 95.08M | 13.56M | 153.00K | 59.00K | 4.97M | 175.00K | 123.65M | 32.41M | 117.60M | 0 |
| Net Change in Cash | 24.06M | 13.16M | 22.63M | 7.13M | 35.16M | 47.62M | -30.04M | -77.77M | 5.36M | -73.16M | 91.94M | 19.55M |
| Free Cash Flow | -48.14M | -46.80M | -45.93M | -52.35M | -38.09M | -50.13M | -36.02M | -32.02M | -21.71M | -28.27M | -23.48M | -28.31M |
This table shows 12 quarterly periods of Annexon's cash flow statement, from Q2 2026 back to Q3 2023, across 10 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow ANNX's reporting calendar. What is a cash flow statement?